The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus
Abstract
Objective: To evaluate whether patients with systemic lupus erythematosus (SLE) have a higher rate of apoptosis in and secondary necrosis of polymorphonuclear neutrophils (PMNs) and macrophages compared with controls; to compare the rate of macrophage phagocytic clearance of apoptotic PMNs in patients with SLE and healthy controls; to evaluate whether in vitro PMN and macrophage apoptosis and secondary necrosis, and the ability of macrophages to phagocytose apoptotic bodies, are correlated with lupus disease activity; and to determine whether macrophage clearance of apoptotic bodies in patients with SLE and normal controls is related to certain serum factors. Methods: Thirty‐six patients with SLE and 18 healthy, nonsmoking volunteers were studied. PMNs and monocytes were isolated from fresh blood and cultured in the presence of different sources of serum. Apoptotic PMNs and macrophages were examined by annexin V binding and morphology on May–Giemsa–stained cytopreparations, at different time points. The presence of secondary necrotic PMNs and macrophages was verified by staining with trypan blue. Macrophage phagocytosis of apoptotic PMNs was measured using a coded, observer‐blinded, microscopically quantified phagocytosis assay. Cells were cultured in the presence of serum obtained from healthy subjects or from patients with SLE. Results: At 5 and 24 hours, the percentage of apoptotic PMNs from patients with SLE was significantly higher than that of PMNs from healthy subjects. At 24 and 48 hours, the percentage of secondary necrotic PMNs from patients with SLE was also significantly higher than the percentage of necrotic PMNs from controls. Serum from patients with SLE accelerated the rate of apoptosis in and secondary necrosis of PMNs from healthy subjects. Macrophages from SLE patients were less capable of phagocytosing apoptotic PMNs compared with macrophages obtained from controls. Macrophages from patients with active SLE were less capable of phagocytosing apoptotic PMNs than were macrophages from patients with inactive SLE, but the difference was not statistically significant. The percentage of phagocytosis of apoptotic PMNs by macrophages from SLE patients correlated negatively with the SLE Disease Activity Index, serum levels of anti–double‐stranded DNA, and the erythrocyte sedimentation rate, and correlated positively with serum levels of C3, C4, and albumin, the hemoglobin level, and the leukocyte count. Serum from SLE patients not only significantly increased macrophage apoptosis in cells from healthy subjects but also remarkably down‐regulated the clearance of apoptotic PMNs by macrophages from healthy subjects. In contrast, serum from healthy subjects significantly increased phagocytosis of apoptotic PMNs by macrophages from SLE patients. Conclusion:
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., & Green, D. R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1545 · Cited by 2,824
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Shrinkage necrosis: A distinct mode of cellular death
Kerr, J. F. R. (1971) · The Journal of Pathology · doi:10.1002/path.1711050103 · Cited by 1,454
Ogden, C. A., deCathelineau, A., Hoffmann, P. R., Bratton, D., Ghebrehiwet, B., Fadok, V. A., & Henson, P. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.781 · Cited by 1,147
Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., & Kalden, J. R. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1241::aid-art15>3.0.co;2-h · Cited by 839
Liang, M. H., Socher, S. A., Larson, M. G., & Schur, P. H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320909 · Cited by 789
Taylor, P. R., Carugati, A., Fadok, V. A., Cook, H. T., Andrews, M., Carroll, M. C., Savill, J. S., Henson, P. M., Botto, M., & Walport, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.359 · Cited by 729
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
Mohan, C., Adams, S., Stanik, V, & Datta, S. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1367 · Cited by 627
Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.
Emlen, W., Niebur, J., & Kadera, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3685 · Cited by 552
Molecular control of neutrophil apoptosis
Akgul, C., Moulding, D. A., & Edwards, S. W. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02324-3 · Cited by 488
Martin, S. J., Finucane, D. M., Amarante-Mendes, G. P., O'Brien, G. A., & Green, D. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28753 · Cited by 372
Apoptosis: The importance of being eaten
Ren, Y., & Savill, J. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400407 · Cited by 347
Self-citationSavill, J. S., Henson, P. M., & Haslett, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114328 · Cited by 291
Kramers, C., Hylkema, M. N., van Bruggen, M. C., van de Lagemaat, R., Dijkman, H. B., Assmann, K. J., Smeenk, R. J., & Berden, J. H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117371 · Cited by 266
Chu, J. L., Drappa, J., Parnassa, A., & Elkon, K. B. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.723 · Cited by 245
Courtney, P. A., Crockard, A. D., Williamson, K., Irvine, A. E., Kennedy, R. J., & Bell, A. L. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.5.309 · Cited by 232
Perniok, A., Wedekind, F., Herrmann, M., Specker, C., & Schneider, M. (1998) · Lupus · doi:10.1191/096120398678919804 · Cited by 212
Amoura, Z., Chabre, H., Koutouzov, S., Lotton, C., Cabrespines, A., Bach, J., & Jacob, L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371118 · Cited by 208
Manfredi, A. A., Rovere, P., Galati, G., Heltai, S., Bozzolo, E., Soldini, L., Davoust, J., Balestrieri, G., Tincani, A., & Sabbadini, M. G. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199802)41:2<205::aid-art4>3.0.co;2-0 · Cited by 205
Lorenz, H., Grünke, M., Hieronymus, T., Herrmann, M., Kühnel, A., Manger, B., & Kalden, J. R. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400216 · Cited by 181
Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.
Georgescu, L., Vakkalanka, R. K., Elkon, K. B., & Crow, M. K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119806 · Cited by 174
Ren, Y., & Savill, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.5.2366 · Cited by 165
Self-citationHartung, K., Baur, M. P., Coldewey, R., et al. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116000 · Cited by 145
Ip, W., Chan, S. Y., Lau, C. S., et al. (1998) · PubMed · Cited by 115
Self-citationHarper, L., Ren, Y., Savill, J., Adu, D., & Savage, C. O. S. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64532-4 · Cited by 107
Self-citationLicht, R., van Bruggen, M. C. J., Oppers‐Walgreen, B., Rijke, T. P. M., & Berden, J. H. M. (2001) · Arthritis & Rheumatism · Cited by 81
Cairns, A. P., Crockard, A. D., McConnell, J. R., Courtney, P. A., & Bell, A. L. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.10.950 · Cited by 77
Lymphocytes, cytokines, inflammation, and immune trafficking
Tsokos, G. C., & Liossis, S. C. (1998) · Current Opinion in Rheumatology · doi:10.1097/00002281-199809000-00004 · Cited by 62
The role of apoptosis in systemic lupus erythematosus
Salmon, M., & Gordon, C. (1999) · Rheumatology · doi:10.1093/rheumatology/38.12.1177 · Cited by 50
What triggers anti-dsDNA antibodies?
i, M. H., Zoller, O., Hagenhofer, M., Voll, R. E., & Kalden, J. R. (1996) · Molecular Biology Reports · doi:10.1007/bf00351179 · Cited by 45
Cited by
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
György, B., Szabó, T. G., Pásztói, M., Pál, Z., Misják, P., Aradi, B., László, V., Pállinger, É., Pap, E., Kittel, Á., et al. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0689-3 · Cited by 2,074
Neutrophil Function: From Mechanisms to Disease
Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D., & Zychlinsky, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074942 · Cited by 1,708
Birge, R. B., Boeltz, S., Kumar, S., Carlson, J., Wanderley, J., Calianese, D., Barcinski, M., Brekken, R. A., Huang, X., Hutchins, J. T., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.11 · Cited by 725
Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease
FADEEL, B., & ORRENIUS, S. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01570.x · Cited by 698
The role of defective clearance of apoptotic cells in systemic autoimmunity
Muñoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A., & Herrmann, M. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.46 · Cited by 627
Metadata
- Authors
- Ren, Y., Tang, J., Mok, M. Y., Chan, A. W. K., Wu, A., & Lau, C. S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2003-10
- Volume
- 48
- Issue
- 10
- Pages
- 2888-2897
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2119566474
- Cited by
- 349
- References
- 35
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.